CA2399276A1 - Nouvelles compositions therapeutiques pour traiter une infection par lawsonia spp - Google Patents

Nouvelles compositions therapeutiques pour traiter une infection par lawsonia spp Download PDF

Info

Publication number
CA2399276A1
CA2399276A1 CA002399276A CA2399276A CA2399276A1 CA 2399276 A1 CA2399276 A1 CA 2399276A1 CA 002399276 A CA002399276 A CA 002399276A CA 2399276 A CA2399276 A CA 2399276A CA 2399276 A1 CA2399276 A1 CA 2399276A1
Authority
CA
Canada
Prior art keywords
plasmid pgte
plasmid
leu
pgte
ile
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002399276A
Other languages
English (en)
Inventor
Everett Lee Rosey
Kendall Wayne King
Robert Trygve Good
Richard Anthony Strugnell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Agriculture Victoria Services Pty Ltd
Australian Pork Ltd
Pfizer Products Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AUPR1381A external-priority patent/AUPR138100A0/en
Application filed by Individual filed Critical Individual
Publication of CA2399276A1 publication Critical patent/CA2399276A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/205Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Campylobacter (G)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53DNA (RNA) vaccination
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

L'invention concerne de manière générale des compositions thérapeutiques pour le traitement et/ou la prévention d'états maladifs des intestins chez les animaux et les oiseaux, causés ou exacerbés par <i>Lawsonia intracellularis</i> ou similaire ou par un micro-organisme apparenté. Plus spécifiquement, cette invention concerne un nouveau gène dérivé de <i>Lawsonia intracellularis</i>, qui code pour un polypeptide immunogène particulièrement utile en tant qu'antigène dans une préparation de vaccin permettant de conférer l'immunité humorale contre <i>Lawsonia intracellularis</i> et des pathogènes apparentés chez des animaux hôtes. Ledit polypeptide est choisi dans le groupe comprenant les polypeptides flhB, fliR, ntrC, glnH, motA, motB, tlyC, ytfM, et ytfN, ou un homologue, analogue ou dérivé d'un ou plusieurs desdits polypeptides. Cette invention concerne également des procédés pour le traitement et/ou la prévention de tels états maladifs des intestins, ainsi que des agents de diagnostic et des procédures permettant de détecter la présence de <i>Lawsonia intracellularis</i> ou similaire ou de micro-organismes apparentés.
CA002399276A 2000-11-10 2001-11-09 Nouvelles compositions therapeutiques pour traiter une infection par lawsonia spp Abandoned CA2399276A1 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
AUPR1381A AUPR138100A0 (en) 2000-11-10 2000-11-10 Novel therapeutic compositions for treating infection by lawsonia spp
AUPR1381 2000-11-10
US24959600P 2000-11-17 2000-11-17
US60/249,596 2000-11-17
PCT/AU2001/001462 WO2002038594A1 (fr) 2000-11-10 2001-11-09 Nouvelles compositions therapeutiques pour traiter une infection par lawsonia spp

Publications (1)

Publication Number Publication Date
CA2399276A1 true CA2399276A1 (fr) 2002-05-16

Family

ID=25646507

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002399276A Abandoned CA2399276A1 (fr) 2000-11-10 2001-11-09 Nouvelles compositions therapeutiques pour traiter une infection par lawsonia spp

Country Status (7)

Country Link
EP (1) EP1332154A4 (fr)
JP (1) JP2004512851A (fr)
BR (1) BR0114835A (fr)
CA (1) CA2399276A1 (fr)
MX (1) MXPA03003077A (fr)
NZ (1) NZ520600A (fr)
WO (1) WO2002038594A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004033631A2 (fr) * 2002-10-04 2004-04-22 Regents Of The University Of Minnesota Sequences d'acides nucleiques et polypeptidiques de lawsonia intracellularis et methodes d'utilisation
US8834891B2 (en) 2005-03-14 2014-09-16 Boehringer Ingelheim Vetmedica, Inc. Immunogenic compositions comprising Lawsonia intracellularis
US8398994B2 (en) 2005-07-15 2013-03-19 Boehringer Ingelheim Vetmedica, Inc. Lawsonia vaccine and methods of use thereof
US20100129397A1 (en) 2006-12-11 2010-05-27 Boehringer Ingelheim Vetmedica, Inc. Effective method of treatment of porcine circovirus and lawsonia intracellularis infections
FR2980213B1 (fr) * 2011-09-16 2013-09-06 Biomerieux Sa Procede de caracterisation de bacteries, par detection de proteines non-structurales de bacteriophages
US9359643B2 (en) 2013-03-08 2016-06-07 Progenika Biopharma S.A. Discrimination of blood type variants
CL2017002196A1 (es) 2017-08-30 2017-11-17 Univ De Concepción Vacuna recombinante contra enteropatía proliferativa en animales.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5885823A (en) * 1995-06-05 1999-03-23 Nobl Laboratories, Inc. Lawsonia intracellularis cultivation, anti-Lawsonia intracellularis vaccines and diagnostic agents
CN1145697C (zh) * 1995-11-30 2004-04-14 维多利亚农业服务控股公司 治疗和诊断组合物
US6627728B1 (en) * 1998-05-12 2003-09-30 Smithkline Beecham Biologicals S.A. Compounds from moraxella catarrhalis
TWI224107B (en) * 1998-10-22 2004-11-21 Pfizer Prod Inc Novel proteins from actinobacillus pleuropneumoniae
GB9902880D0 (en) * 1999-02-09 1999-03-31 Smithkline Beecham Biolog Novel compounds

Also Published As

Publication number Publication date
MXPA03003077A (es) 2003-09-25
JP2004512851A (ja) 2004-04-30
WO2002038594A1 (fr) 2002-05-16
BR0114835A (pt) 2003-07-01
EP1332154A4 (fr) 2005-05-11
EP1332154A1 (fr) 2003-08-06
NZ520600A (en) 2004-08-27
WO2002038594A9 (fr) 2002-11-07

Similar Documents

Publication Publication Date Title
US20060018920A1 (en) Lawsonia derived gene and related OmpH polypeptides, peptides and proteins and their uses
US20060159707A1 (en) Lawsonia derived gene and related FlgE polypeptides, peptides and proteins and their uses
WO2008017636A2 (fr) Nouveaux gènes et nouvelles protéines de brachyspira hyodysenteriae et leurs utilisations
AU771376B2 (en) Lawsonia derived gene and related FlgE polypeptides, peptides and proteins and their uses
CA2399276A1 (fr) Nouvelles compositions therapeutiques pour traiter une infection par lawsonia spp
AU775323B2 (en) Lawsonia derived gene and related hemolysin polypeptides, peptides and proteins and their uses
CA2372095A1 (fr) Gene derive de $i(lawsonia) et polypeptides, peptides et proteines sodc associes, et leurs utilisations
US7052697B1 (en) Lawsonia derived gene and related OmpH polypeptides, peptides and proteins and their uses
US6846487B2 (en) Therapeutic compositions for treating infection by Lawsonia spp.
EP2530087B1 (fr) séquences de Brachyspira, compositions immunogènes, procédés pour leur préparation et utilisation
AU780980B2 (en) Novel therapeutic compositions for treating infection by lawsonia SPP
US7029683B1 (en) Lawsonia derived gene and related hemolysin polypeptides, peptides and proteins and their uses
EP2363407A1 (fr) Nouvelles séquences de Brachyspira, compositions immunogènes, procédés pour leur préparation et utilisation
AU2013360773B2 (en) Novel recombinant outer membrane proteins from Brachyspira hyodysenteriae and uses thereof
SG185943A1 (en) Genes and proteins of brachyspira hyodysenteriae and uses thereof

Legal Events

Date Code Title Description
FZDE Discontinued